Related Experiment Videos
Stimulant treatment for children: a community perspective
Summary
Prescribed stimulant use for attention-deficit hyperactivity disorder (ADHD) in children was inconsistent with diagnostic guidelines. Many children receiving stimulants did not meet full ADHD criteria, while some diagnosed with ADHD were undertreated.
Area of Science:
- Child and Adolescent Psychiatry
- Neurodevelopmental Disorders
- Pediatric Pharmacology
Background:
- Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Stimulant medications are a primary treatment for ADHD.
- Understanding patterns of stimulant prescription is crucial for effective pediatric care.
Purpose of the Study:
- To investigate the relationship between prescribed stimulant use and research diagnoses of ADHD in a community sample of children.
- To assess adherence to diagnostic guidelines in stimulant prescription.
Main Methods:
- Analysis of longitudinal data from the Great Smoky Mountains Study.
- Inclusion of 9- to 16-year-olds across 4 annual interview waves.
- Examination of ADHD diagnoses, symptom severity, and stimulant treatment receipt.
Main Results:
- Nearly three-quarters of children with a clear ADHD diagnosis received stimulant medication over 4 years.
- Girls and older children with ADHD were less likely to receive stimulants.
- Many children receiving stimulants did not meet full DSM-III-R ADHD criteria, often having oppositional defiant disorder and subthreshold ADHD symptoms.
Conclusions:
- Stimulant treatment patterns in this community sample deviated significantly from established diagnostic guidelines for ADHD.
- There is a need to re-evaluate prescribing practices to align with diagnostic criteria and ensure appropriate patient care.